Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Orexigen and Takeda to co-commercialize Contrave in North America

Sep. 3, 2010

MorphoSys and Absynth partner for MRSA treatments

Sep. 3, 2010

HUYA and Sun Yat-sen University to develop novel drugs in China

Sep. 2, 2010

Ono receives exclusive rights in Japan to salirasib

Sep. 2, 2010

IntelGenx and RedHill sign agreement for migraine film product

Sep. 2, 2010

BTG to receive marketing rights for Nycomed's CroFab and DigiFab

Sep. 1, 2010

Bioniche and University of Ottawa sign agreement for antianxiety compounds

Aug. 31, 2010

Shionogi and LifeCycle end North American license agreement for Fenoglide

Aug. 31, 2010

Antitope and Ablynx to collaborate in developing Nanobodies

Aug. 30, 2010

Marina Biotech sells carbetocin assets to Cypress Bioscience

Aug. 30, 2010

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...